|
Bioasis Announces Registration and Grant Notice of Patent Application in China Relating to xB3 Platform Technology
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 22, 2019 09:45AM
|
|
Re: Age, MoCA and CKD
|
1
|
Resverlogix Corp.
|
Nov 19, 2019 09:05AM
|
|
biOasis Announces the Issuance of a Key US Patent
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 12, 2015 02:22PM
|
|
Re: ESC 2017 Abstracts are up
|
1
|
Resverlogix Corp.
|
Aug 24, 2017 12:17PM
|
|
Re: News out...an extension it is
|
1
|
Resverlogix Corp.
|
Aug 28, 2017 09:07AM
|
|
Re: Bio Europe - Resverlogix Presenting
|
1
|
Resverlogix Corp.
|
Oct 21, 2017 07:58AM
|
|
Re: AGM
|
1
|
Zenith Epigenetics
|
Jun 21, 2021 08:25AM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
1
|
Resverlogix Corp.
|
Jun 14, 2019 11:48AM
|
|
Re: biOasis Technologies Inc BTI:TSXV - News Alert
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 22, 2019 09:47AM
|
|
Re: Stability
|
1
|
Resverlogix Corp.
|
Nov 23, 2015 11:30AM
|
|
Re: Odd About The Disappearing Presentation
|
1
|
Resverlogix Corp.
|
May 22, 2017 09:28AM
|
|
Re: Draft Checklist for Management
|
1
|
Resverlogix Corp.
|
Jul 25, 2016 02:17PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:01AM
|
|
Re: Timing of BETonMACE data
|
1
|
Resverlogix Corp.
|
Jun 10, 2019 03:06PM
|
|
Nichols review of SUSTAIN and ASSURE
|
1
|
Resverlogix Corp.
|
Dec 05, 2016 04:20PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
1
|
Resverlogix Corp.
|
Jan 09, 2019 09:35AM
|
|
Re: Current Status of Draft Checklist... thumbs up...!
|
1
|
Resverlogix Corp.
|
Jul 28, 2016 08:58AM
|
|
Re: June 7: Delivering Across the Blood Brain Barrier - Crossing the Final Frontier
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 18, 2016 11:08AM
|
|
Re: ESPR
|
1
|
Resverlogix Corp.
|
Jun 29, 2016 11:25AM
|
|
Re: Near Final Draft of Checklist for Management - A Few More Spelling changes
|
1
|
Resverlogix Corp.
|
Jul 28, 2016 08:59AM
|
